We just received data on a new analyst forecast for $BDX. William Blair gave a rating of 'Market Perform' for $BDX.
$BDX Analyst Ratings
Wall Street analysts have issued reports on $BDX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 04/23/2025
- UBS issued a "Buy" rating on 12/18/2024
To track analyst ratings and price targets for $BDX, check out Quiver Quantitative's $BDX forecast page.
$BDX Congressional Stock Trading
Members of Congress have traded $BDX stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 03/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BDX Insider Trading Activity
$BDX insiders have traded $BDX stock on the open market 14 times in the past 6 months. Of those trades, 1 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- ROLAND GOETTE (EVP and President, EMEA) has made 0 purchases and 2 sales selling 5,121 shares for an estimated $1,130,528.
- MICHAEL DAVID GARRISON (EVP & President, Medical) has made 0 purchases and 3 sales selling 3,914 shares for an estimated $869,504.
- SHANA CAROL NEAL (EVP and Chief People Officer) has made 0 purchases and 3 sales selling 2,575 shares for an estimated $594,550.
- RICHARD BYRD (EVP & President Interventional) has made 0 purchases and 2 sales selling 2,399 shares for an estimated $541,895.
- DAVID SHAN (EVP and Chief ISC Officer) has made 0 purchases and 2 sales selling 2,000 shares for an estimated $450,375.
- JEFFREY WILLIAM HENDERSON purchased 1,500 shares for an estimated $350,430
- BERTRAM L SCOTT sold 700 shares for an estimated $159,593
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BDX Hedge Fund Activity
We have seen 696 institutional investors add shares of $BDX stock to their portfolio, and 768 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,219,317 shares (+36.1%) to their portfolio in Q4 2024, for an estimated $730,366,447
- KOVITZ INVESTMENT GROUP PARTNERS, LLC added 2,722,829 shares (+392.4%) to their portfolio in Q4 2024, for an estimated $617,728,215
- CITADEL ADVISORS LLC added 1,398,984 shares (+376.2%) to their portfolio in Q4 2024, for an estimated $317,387,500
- BANK OF NEW YORK MELLON CORP removed 1,388,519 shares (-42.6%) from their portfolio in Q1 2025, for an estimated $318,054,162
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,251,742 shares (-9.2%) from their portfolio in Q4 2024, for an estimated $283,982,707
- BANK OF AMERICA CORP /DE/ added 1,098,633 shares (+77.8%) to their portfolio in Q4 2024, for an estimated $249,246,868
- NEUBERGER BERMAN GROUP LLC removed 1,071,696 shares (-76.1%) from their portfolio in Q4 2024, for an estimated $243,135,671
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
